Topical nicotinamide mononucleotide is a vitamin B3-related molecule applied to skin in the hope of restarting thinning scalp hair. The interest is longevity: follicles are busy tissue, and the energy-transfer molecule this preparation feeds declines with age. The regrowth signal is from mouse skin after hair removal and human follicle cells in a dish, not trials in people. A breakdown product slowed human follicles kept outside the body. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Terminal hair density (thick scalp hairs) | No established target; track change from the person's own baseline | Shows whether more thick scalp hairs are present |
| Hair-shaft diameter | No established target; track microns against the person's own baseline | Thinning shafts mark miniaturization (shafts shrinking) |
| Ferritin | 50–100 ng/mL | Low iron stores cause shedding unrelated to the topical |
| TSH | 0.5–2.5 mIU/L | Thyroid excess or deficiency changes the hair cycle |
| 25-hydroxyvitamin D | 40–60 ng/mL | Deficiency is a reversible contributor to shedding |
Cadence: Baseline photographs and a same-site hair count before any reading of a topical preparation. Photographs and, where available, a phototrichogram (magnified hair count) at 12 weeks and then every 6 months. Labs repeat only if the baseline value was outside the range being tracked.